Eliem Therapeutics Inc.

NASDAQ: ELYM · Real-Time Price · USD
5.11
-0.05 (-0.97%)
At close: Oct 02, 2024, 10:00 PM

Eliem Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-2.68 -2.07 -2.13 -5.78
PEG Ratio
-0.15 0.08 0.43 -0.02
PS Ratio
n/a n/a n/a n/a
PB Ratio
0.93 0.68 0.75 1.64
P/FCF Ratio
-12.72 -3.54 -2.58 -7.61
P/OCF Ratio
-12.72 -3.54 -2.58 -7.61
OCF/S Ratio
n/a n/a n/a n/a
Debt / Equity Ratio
0.00 0.00 0.00 n/a
Quick Ratio
31.41 38.92 23.11 23.85
Current Ratio
31.41 38.92 22.04 24.58
Asset Turnover
n/a n/a n/a n/a
Interest Coverage
n/a n/a -28.33 n/a
Return on Equity
-0.35 -0.33 -0.35 -0.28
Return on Assets
-0.34 -0.32 -0.34 -0.27
Return on Invested Capital
-0.39 -0.2 -0.35 -0.21
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a n/a n/a
Net Profit Margin
n/a n/a n/a n/a
Pretax Profit Margin
n/a n/a n/a n/a
Operating Profit Margin
n/a n/a n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a n/a n/a